Workflow
PHUA LEE MING(002957)
icon
Search documents
科瑞技术(002957) - 第四届监事会第十六次会议决议公告
2025-07-21 09:45
深圳科瑞技术股份有限公司(以下简称"公司")第四届监事会第十六次会 议于2025年7月21日以现场会议形式召开。本次监事会会议通知及会议材料已于 2025年7月18日以电子邮件方式向公司全体监事发出。会议由监事会主席谭慧姬 女士主持。本次会议应出席监事3人,实际出席监事3人。公司董事会秘书、证券 事务代表列席了会议。本次会议的召集、召开符合有关法律、行政法规、部门规 章、规范性文件和公司章程的规定。 证券代码:002957 证券简称:科瑞技术 公告编号:2025-046 深圳科瑞技术股份有限公司 第四届监事会第十六次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 一、监事会会议召开情况 三、备查文件 特此公告。 深圳科瑞技术股份有限公司 二、监事会会议审议情况 经与会监事认真审议,本次会议审议通过了如下议案: (一) 审议《关于出售全资子公司股权并转让相关资产的议案》 公司出售中山科瑞及转让相关专用设备符合公司发展战略,本次交易的审批 程序合法合规,不存在损害公司及股东利益的情形。本次资产出售事项的交易标 的价格经专业评估机构进行评估,评估方法合 ...
科瑞技术(002957) - 第四届董事会第二十一次会议决议公告
2025-07-21 09:45
本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 一、董事会会议召开情况 深圳科瑞技术股份有限公司(以下简称"公司")第四届董事会第二十一次 会议于2025年7月21日以现场和通讯方式召开。本次董事会会议通知及会议材料 已于2025年7月18日以电子邮件方式向公司全体董事发出。会议由董事长PHUA LEE MING先生主持。本次会议应出席董事9人(含3位独立董事),实际出席董 事9人。公司监事、董事会秘书及部分高级管理人员列席本次会议。本次会议的 召集、召开符合相关法律、行政法规、部门规章、规范性文件和公司章程的规定。 证券代码:002957 证券简称:科瑞技术 公告编号:2025-045 深圳科瑞技术股份有限公司 第四届董事会第二十一次会议决议公告 二、董事会会议审议情况 经与会董事认真审议,本次会议审议通过了如下议案: (一) 审议通过《关于出售全资子公司股权并转让相关资产的议案》 综合考虑公司产品所属行业、市场需求及未来发展规划,为进一步提高资产 使用率及提升运营效率,拟将中山科瑞自动化技术有限公司(以下简称"中山科 瑞")出让给深圳市北鼎晶辉科技股份有限 ...
7月4日体外诊断上涨0.24%,板块个股热景生物、塞力医疗涨幅居前
Sou Hu Cai Jing· 2025-07-04 09:36
Core Viewpoint - The in vitro diagnostics sector experienced a slight increase of 0.24% on July 4, with a net outflow of funds amounting to 42.33 million [1] Group 1: Market Performance - A total of 18 stocks in the sector saw gains, while 49 stocks declined [1] - The top decliners included Dongfang Ocean (-6.51%), Xilong Scientific (-3.81%), and Nearshore Protein (-2.54%) [1][1] Group 2: Stock Performance - Notable gainers included: - Hotgen Biotech with a price of 194.81 and an increase of 20.08%, attracting a net fund inflow of 2.125 million [1] - Saily Medical at 21.08, up 10.02%, with a net inflow of 1.758 million [1] - Zhongyuan Union at 25.87, rising 9.99%, with a net inflow of 1.38 billion [1] - Decliners included: - Botao Biotech at 37.34, down 3.38%, with a net outflow of 1.087 million [1] - Maike Biotech at 7.99, down 2.44%, with a net inflow of 176.92 thousand [1]
科瑞技术: 2024年年度权益分派实施公告
Zheng Quan Zhi Xing· 2025-06-16 09:11
Core Points - The company has announced the implementation of the 2024 annual profit distribution plan, which was approved at the shareholders' meeting on May 30, 2025 [1] - The profit distribution plan includes a cash dividend of 1.70 RMB per 10 shares (before tax) to all shareholders, based on the total share capital minus the shares in the company's repurchase account [1][2] - The total share capital as of April 24, 2025, is 419,982,466 shares, with 2,333,442 shares in the repurchase account, resulting in 417,649,024 shares eligible for the dividend distribution [1][2] Profit Distribution Plan - The cash dividend distribution will be differentiated based on the type of shares held, with specific tax treatments for different categories of investors [2] - The cash dividend for investors holding shares for less than one month will incur a tax of 0.34 RMB per 10 shares, while those holding for more than one month but less than one year will incur a tax of 0.17 RMB per 10 shares [2] - The record date for the dividend distribution is set for June 20, 2025, and the ex-dividend date is June 23, 2025 [2][3] Dividend Calculation - The actual cash dividend per share, after adjustments, is approximately 0.1690554 RMB per share [3] - The ex-dividend reference price will be calculated based on the previous closing price minus the cash dividend [3] Dividend Recipients - The recipients of the dividend will be all shareholders registered with the China Securities Depository and Clearing Corporation Limited, Shenzhen Branch, as of the record date [4] Distribution Method - The cash dividends will be directly credited to the shareholders' accounts through their securities companies or other custodians [4] - The company assumes all legal responsibilities for any discrepancies in the cash dividend distribution due to changes in shareholders' account balances [4] Adjustment of Parameters - The company will adjust the minimum selling price for shares held by certain shareholders in accordance with the profit distribution [6]
科瑞技术(002957) - 2024年年度权益分派实施公告
2025-06-16 09:00
证券代码:002957 证券简称:科瑞技术 公告编号:2025-044 深圳科瑞技术股份有限公司(以下简称"公司"或"科瑞技术"),2024 年年度 利润分配预案已获 2025 年 5 月 30 日召开的 2024 年度股东大会审议通过,现将 权益分派事宜公告如下: 关于 2024 年年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有 虚假记载、误导性陈述或重大遗漏。 一、股东大会审议通过的利润分配预案等情况 1、公司 2024 年度股东大会通过的利润分配预案情况如下: 以实施权益分派股权登记日登记的总股本扣除公司回购专用账户中的股份 为基数,向全体股东每 10 股派发现金红利 1.70 元(含税),剩余未分配利润结 转下一年度。截至 2025 年 4 月 24 日,即本次利润分配方案的董事会召开日,公 司总股本 419,982,466 股,公司回购专用账户中的股数为 2,333,442 股,以总股本 扣减公司回购专用账户后的股数 417,649,024 股为基数测算,预计派发现金红利 71,000,334.08 元(含税)。2024 年度公司不送红股,不进行资本公积金转增股 ...
科瑞技术(002957) - 关于使用部分自有闲置资金进行证券投资的进展公告
2025-06-13 07:45
证券代码:002957 证券简称:科瑞技术 公告编号:2025-043 关于使用部分自有闲置资金进行证券投资的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 深圳科瑞技术股份有限公司(以下简称"公司"或"科瑞技术")于 2025 年 4 月 24 日召 开第四届董事会第十九次会议、第四届监事会第十五次会议以及 2025 年 5 月 30 日召开 的 2024 年年度股东大会,审议通过了《关于使用自有闲置资金进行证券投资的议案》, 为促进公司发展,合理利用自有资金,提高资金使用效率与效益,增加资金收益,同意公 司及子公司在充分保障日常运营性资金需求、不影响公司及子公司正常生产经营并有效 控制风险的前提下,使用自有闲置资金用于证券投资,投资最高额度不超过 95,000 万元 人民币,该额度在经审批的投资期限内可以循环滚动使用,授权总经理签署相关合同,由 财务部门负责具体组织实施。本议案已经股东大会审议,有效期自股东大会审议通过之日 起 12 个月,具体内容详见公司刊登在《证券时报》《中国证券报》《上海证券报》《证 券日报》和巨潮资讯网(http://ww ...
科瑞技术控股股东等3个月减持720万股 套现1.26亿元
Zhong Guo Jing Ji Wang· 2025-06-13 03:23
Core Viewpoint - The announcement details the completion of share reduction plans by major shareholders of Kory Technology, indicating a decrease in their ownership stakes without affecting the company's control or governance structure [1][6]. Shareholder Reduction Summary - Colibri Technologies PTE LTD reduced its shareholding from 38.1003% to 37.1003%, selling 4,176,400 shares at an average price of 17.89 CNY per share, totaling approximately 74.67 million CNY [2][3][4]. - Hua Miao Investment reduced its stake from 15.4089% to 14.9713%, selling 1,827,702 shares at an average price of 17.91 CNY per share, totaling approximately 32.69 million CNY [2][3][4]. - Eagle Investment sold 1,200,000 shares at an average price of 15.87 CNY per share, reducing its stake from 7.5077% to 7.2203%, totaling approximately 19.04 million CNY [2][3][4]. Total Reduction Impact - The total shares reduced by the three entities amounted to 7,204,100 shares, with a total reduction value of approximately 126 million CNY [3][4]. Company Background - Kory Technology was listed on the Shenzhen Stock Exchange on July 26, 2019, with an initial issuance of 41 million shares at a price of 15.10 CNY per share, raising a total of 619 million CNY [6][7]. - The company’s actual controller is Phua Lee Ming, who has served as chairman since October 2013 [6].
科瑞技术: 关于控股股东、持股5%以上股东及部分高级管理人员股份减持计划期限届满的公告
Zheng Quan Zhi Xing· 2025-06-12 12:53
Summary of Key Points Core Viewpoint - The announcement details the completion of the share reduction plan by major shareholders of Shenzhen Keri Technology Co., Ltd, including the controlling shareholder and other significant stakeholders, confirming that the information provided is accurate and complete [1]. Shareholder Reduction Plan and Implementation Progress - The controlling shareholder, Colibri Technologies Pte Ltd, reduced its shareholding from 38.1003% to an undisclosed percentage after selling 4,176,400 shares between March 13, 2025, and June 12, 2025 [2]. - Hua Miao Investment Co., Ltd. reduced its shareholding from 15.4089% to 14.9713% after selling 1,827,702 shares, representing a reduction of 0.4376% [2]. - Qingdao Eagle Investment Co., Ltd. sold 1,200,000 shares, decreasing its holding from 7.5077% to 7.2203%, a reduction of 0.2873% [2]. - Senior management members, Li Dandan and Rao Lele, did not reduce their shareholdings during this period [2]. Shareholding Situation Before and After Reduction - The total share capital of the company increased from 410,762,170 shares to 419,982,466 shares due to a specific issuance of 9,220,296 shares, which became tradable on March 10, 2025 [4]. - The effective shareholding base for the reduction calculations was adjusted to 417,649,024 shares after excluding 2,333,442 shares held in the repurchase account [4]. Compliance with Regulations - The reduction was conducted in accordance with relevant laws and regulations, including the Securities Law and the Shenzhen Stock Exchange's guidelines, confirming that the actual reduction quantities were within the planned limits [5].
科瑞技术(002957) - 关于控股股东、持股5%以上股东及部分高级管理人员股份减持计划期限届满的公告
2025-06-12 12:18
关于控股股东、持股5%以上股东及部分高级管理人员股份减持计划期限 届满的公告 控股股东COLIBRI TECHNOLOGIES PTE LTD、持股5%以上的股东深圳市华苗投资 有限公司、青岛鹰诺投资有限公司、高级管理人员李单单女士、饶乐乐先生保证向本公司 提供的信息内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 证券代码:002957 证券简称:科瑞技术 公告编号:2025-042 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 深圳科瑞技术股份有限公司 根据《证券法》《上市公司股东减持股份管理暂行办法》《深圳证券交易所上市公司 自律监管指引第 18 号——股东及董事、监事、高级管理人员减持股份》等相关法律法规 及规范性文件的规定,现将相关情况公告如下: 一、 股东股份减持计划及实施进展情况 公司于 2025 年 2 月 19 日披露了《关于控股股东、持股 5%以上股东及部分高级管理 人员股份减持计划预披露公告》(公告编号:2025-009),新加坡科瑞技术、华苗投资、 鹰诺投资、李单单女士、饶乐乐先生计划通过集中竞价、大宗交易等深圳证券交易所认可 的合法方式减持公司股份。新 ...
科瑞技术:股东减持股份计划期限届满
news flash· 2025-06-12 12:14
Group 1 - Core viewpoint: The announcement details the completion of the share reduction plan by major shareholders of Kory Technology, indicating a strategic shift in ownership structure [1] - Kory Technology's controlling shareholder, Singapore Kory Technology, reduced its stake from 38.1003% to 37.1003%, totaling a reduction of 4.1764 million shares, representing a decrease of 1.0000% [1] - Hua Miao Investment decreased its holdings from 15.4089% to 14.9713%, with a total reduction of 1.8277 million shares, equating to a decrease of 0.4376% [1] - Eagle Investment reduced its stake from 7.5077% to 7.2203%, with a total of 1.2 million shares sold, representing a decrease of 0.2873% [1] - Senior management personnel, Li Dandan and Rao Lele, did not reduce their shareholdings during this period [1]